HCP Live: Experts' Perspectives: Top Story in Heart Failure for 2023

Few fields can lay claim to the level of advancements and breakthroughs as heart failure in the last decade. Not only has the field been the beneficiary of novel agents ascending into guideline-directed medical therapy, but it has also witnessed revelations surrounding the overlap of cardiometabolic disease give birth to a new concept: cardiovascular-kidney-metabolic syndrome, which the American Heart Association recently recognized in a scientific statement.

HCP Live Cardiology polled nine heart failure experts on what they believed what was the headlining story in heart failure from the past year, including Dr. Mikhail Kosiborod, Vice President of Research at Saint Luke's Health System.

Read the full HCP Live article: Experts' Perspectives: Top Story in Heart Failure for 2023

 

Related Content

Sep. 29, 2023

HCP Live: Report: More Than 25% of U.S. Adults Has One or More Cardiac, Renal, or Metabolic Conditions
Researchers at Saint Luke's Mid America Heart Institute took part in an analysis examining two decades of trends in the prevalence and overlap of cardiac, renal, and metabolic conditions among U.S. adults.
Sep. 21, 2023

Healio: Minimally Symptomatic Patients Likely to Survive with Good Health Status After TAVR

Dr. Chetan Huded and colleagues found patients with minimal symptoms who underwent TAVR were more likely to survive with good health status at one year than more symptomatic patients.
Sep. 21, 2023

Medpage Today: Reassuring Registry Data on Going Into TAVR Sans Symptoms
Transcatheter aortic valve replacement (TAVR) got some preliminary affirmation for asymptomatic or minimally symptomatic severe aortic stenosis in a retrospective registry study.